|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 2247 for Erbb2

0.041s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication
First Author: Xie W
Year: 1999
Journal: Oncogene
Title: Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice.
Volume: 18
Issue: 24
Pages: 3593-607
Publication
First Author: Atanasoski S
Year: 2006
Journal: J Neurosci
Title: ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury.
Volume: 26
Issue: 7
Pages: 2124-31
Publication
First Author: Huck L
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.
Volume: 107
Issue: 35
Pages: 15559-64
Publication
First Author: Hirai M
Year: 2017
Journal: J Clin Invest
Title: Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation.
Volume: 127
Issue: 2
Pages: 569-582
Publication
First Author: Kim K
Year: 2011
Journal: Biochem Biophys Res Commun
Title: Epiregulin-dependent amphiregulin expression and ERBB2 signaling are involved in luteinizing hormone-induced paracrine signaling pathways in mouse ovary.
Volume: 405
Issue: 2
Pages: 319-24
Publication  
First Author: Liu J
Year: 2019
Journal: Cells
Title: ERBB2 Regulates MED24 during Cancer Progression in Mice with Pten and Smad4 Deletion in the Pulmonary Epithelium.
Volume: 8
Issue: 6
Publication
First Author: Chaturvedi R
Year: 2014
Journal: Gastroenterology
Title: Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.
Volume: 146
Issue: 7
Pages: 1739-51.e14
Publication
First Author: Britsch S
Year: 1998
Journal: Genes Dev
Title: The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system.
Volume: 12
Issue: 12
Pages: 1825-36
Publication
First Author: Meyers N
Year: 2020
Journal: Sci Rep
Title: Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma.
Volume: 10
Issue: 1
Pages: 5241
Publication
First Author: Xi C
Year: 2012
Journal: J Biol Chem
Title: Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis.
Volume: 287
Issue: 42
Pages: 35646-35657
Publication
First Author: Moscoso LM
Year: 1995
Journal: Dev Biol
Title: Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in developing mammalian muscle.
Volume: 172
Issue: 1
Pages: 158-69
GXD Expression    
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:6190223
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Erbb2
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689421
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6190223
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Erbb2
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689424
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6190223
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Erbb2
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689426
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:6190223
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Erbb2
Detected: true
Specimen Num: 4
GXD Expression      
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190223
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Erbb2
Detected: false
Specimen Num: 5
GXD Expression      
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190223
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Erbb2
Detected: false
Specimen Num: 6
GXD Expression      
Probe: MGI:6172103
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6190223
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Erbb2
Detected: false
Specimen Num: 7
Publication
First Author: Dillon RL
Year: 2007
Journal: Mol Cell Biol
Title: An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer.
Volume: 27
Issue: 24
Pages: 8648-57
Publication
First Author: Lim H
Year: 1997
Journal: Endocrinology
Title: Differential expression of the erbB2 gene in the periimplantation mouse uterus: potential mediator of signaling by epidermal growth factor-like growth factors.
Volume: 138
Issue: 3
Pages: 1328-37
Publication  
First Author: Ordonez LD
Year: 2021
Journal: Dis Model Mech
Title: Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
Volume: 14
Issue: 5
Publication
First Author: Basak P
Year: 2018
Journal: Genes Chromosomes Cancer
Title: In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Volume: 57
Issue: 4
Pages: 182-191
Publication
First Author: Zhang J
Year: 2018
Journal: Eur J Neurosci
Title: ERBB2 signaling drives supporting cell proliferation in vitro and apparent supernumerary hair cell formation in vivo in the neonatal mouse cochlea.
Volume: 48
Issue: 10
Pages: 3299-3316
Publication
First Author: Huang YZ
Year: 2001
Journal: J Biol Chem
Title: Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95.
Volume: 276
Issue: 22
Pages: 19318-26
Publication
First Author: Cooley MA
Year: 2012
Journal: Dev Dyn
Title: Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.
Volume: 241
Issue: 2
Pages: 303-14
Publication
First Author: Shawer H
Year: 2020
Journal: PLoS One
Title: A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure.
Volume: 15
Issue: 6
Pages: e0233007
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Publication
First Author: Borg JP
Year: 2000
Journal: Nat Cell Biol
Title: ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor.
Volume: 2
Issue: 7
Pages: 407-14
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein
Organism: Mus musculus/domesticus
Length: 519  
Fragment?: true
Publication
First Author: Rachmin I
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Erbin is a negative modulator of cardiac hypertrophy.
Volume: 111
Issue: 16
Pages: 5902-7
Publication
First Author: Liang C
Year: 2012
Journal: J Neurosci
Title: Erbin is required for myelination in regenerated axons after injury.
Volume: 32
Issue: 43
Pages: 15169-80
Publication
First Author: Sørensen LL
Year: 2016
Journal: Comp Med
Title: Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2.
Volume: 66
Issue: 4
Pages: 268-77
Publication
First Author: Schade B
Year: 2013
Journal: Cancer Res
Title: β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
Volume: 73
Issue: 14
Pages: 4474-87
Publication
First Author: Xie W
Year: 1998
Journal: Cell Growth Differ
Title: Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
Volume: 9
Issue: 4
Pages: 313-25
Publication
First Author: Quan L
Year: 2012
Journal: Genes Chromosomes Cancer
Title: Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
Volume: 51
Issue: 7
Pages: 631-43
Publication
First Author: Tao Y
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Role of Erbin in ErbB2-dependent breast tumor growth.
Volume: 111
Issue: 42
Pages: E4429-38
Publication
First Author: Li J
Year: 2015
Journal: Mol Cell Biol
Title: Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.
Volume: 35
Issue: 23
Pages: 4069-82
Publication  
First Author: Peng M
Year: 2015
Journal: Cell Death Dis
Title: Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
Volume: 6
Pages: e1848
Publication
First Author: Muraoka RS
Year: 2002
Journal: Mol Cell Biol
Title: ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
Volume: 22
Issue: 7
Pages: 2204-19
Publication
First Author: Andrechek ER
Year: 2003
Journal: Cancer Res
Title: Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.
Volume: 63
Issue: 16
Pages: 4920-6
Publication
First Author: Andrechek ER
Year: 2005
Journal: Oncogene
Title: Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.
Volume: 24
Issue: 5
Pages: 932-7
Publication
First Author: Simond AM
Year: 2022
Journal: Oncogene
Title: Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer.
Volume: 41
Issue: 25
Pages: 3445-3451
Publication
First Author: Liu M
Year: 2005
Journal: Cancer Res
Title: Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.
Volume: 65
Issue: 12
Pages: 5325-36
Publication
First Author: Ling C
Year: 2012
Journal: Cancer Discov
Title: Loss of the 14-3-3σ tumor suppressor is a critical event in ErbB2-mediated tumor progression.
Volume: 2
Issue: 1
Pages: 68-81
Publication
First Author: Kiguchi K
Year: 2001
Journal: Cancer Res
Title: Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma.
Volume: 61
Issue: 19
Pages: 6971-6
Publication
First Author: Tung B
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
Volume: 114
Issue: 5
Pages: E707-E716
Publication
First Author: Hulit J
Year: 2006
Journal: Cancer Res
Title: p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Volume: 66
Issue: 17
Pages: 8529-41
Publication
First Author: Hodgson JG
Year: 2005
Journal: Cancer Res
Title: Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling.
Volume: 65
Issue: 21
Pages: 9695-704
Publication
First Author: Tao Y
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Erbin regulates NRG1 signaling and myelination.
Volume: 106
Issue: 23
Pages: 9477-82
HT Experiment  
Experiment Type: transcription profiling by array
Study Type: WT vs. Mutant
Source: GEO
Publication
First Author: Rao GN
Year: 2000
Journal: Breast Cancer Res Treat
Title: Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene.
Volume: 64
Issue: 3
Pages: 287-96
Publication  
First Author: Yang H
Year: 2024
Journal: EBioMedicine
Title: A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice.
Volume: 106
Pages: 105260
Publication
First Author: Guy CT
Year: 1992
Journal: Proc Natl Acad Sci U S A
Title: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
Volume: 89
Issue: 22
Pages: 10578-82
Publication
First Author: Rovero S
Year: 2001
Journal: Gene Ther
Title: Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice.
Volume: 8
Issue: 6
Pages: 447-52
Publication
First Author: Muthuswamy SK
Year: 1994
Journal: Mol Cell Biol
Title: Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Volume: 14
Issue: 1
Pages: 735-43
Publication
First Author: Siegel PM
Year: 1994
Journal: Mol Cell Biol
Title: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
Volume: 14
Issue: 11
Pages: 7068-77
Publication  
First Author: Muller WJ
Year: 1998
Journal: Biochem Soc Symp
Title: Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer.
Volume: 63
Pages: 149-57
Publication
First Author: Zhou H
Year: 2001
Journal: Oncogene
Title: MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Volume: 20
Issue: 42
Pages: 6009-17
Publication
First Author: Andrechek ER
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.
Volume: 97
Issue: 7
Pages: 3444-9
Publication
First Author: Montagna C
Year: 2002
Journal: Oncogene
Title: Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu.
Volume: 21
Issue: 6
Pages: 890-8
Publication
First Author: Jäger R
Year: 2005
Journal: Breast Cancer Res Treat
Title: Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Volume: 90
Issue: 3
Pages: 273-80
Publication
First Author: Shepherd TG
Year: 2001
Journal: Curr Biol
Title: The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
Volume: 11
Issue: 22
Pages: 1739-48
Publication
First Author: Wu L
Year: 2015
Journal: Oncogene
Title: Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis.
Volume: 34
Issue: 1
Pages: 119-28
Publication
First Author: Lucchini F
Year: 1992
Journal: Cancer Lett
Title: Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice.
Volume: 64
Issue: 3
Pages: 203-9
Publication
First Author: Weinstein EJ
Year: 2000
Journal: Mol Med
Title: A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene.
Volume: 6
Issue: 1
Pages: 4-16
Publication
First Author: Marchini C
Year: 2011
Journal: PLoS One
Title: The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.
Volume: 6
Issue: 4
Pages: e18727
Publication
First Author: Lo Iacono M
Year: 2005
Journal: Int J Immunopathol Pharmacol
Title: A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
Volume: 18
Issue: 2
Pages: 351-63
Publication
First Author: Li B
Year: 1997
Journal: Mol Cell Biol
Title: neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
Volume: 17
Issue: 6
Pages: 3155-63
Publication
First Author: Mukherjee S
Year: 2000
Journal: Oncogene
Title: Ductal growth is impeded in mammary glands of C-neu transgenic mice.
Volume: 19
Issue: 52
Pages: 5982-7
Publication
First Author: Trimble MS
Year: 1993
Journal: Oncogene
Title: PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Volume: 8
Issue: 11
Pages: 3037-42
Publication
First Author: Holloway KR
Year: 2015
Journal: PLoS One
Title: Krt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.
Volume: 10
Issue: 1
Pages: e0117239
Publication
First Author: Amici A
Year: 1998
Journal: Cancer Immunol Immunother
Title: Genetic immunization against neu/erbB2 transgenic breast cancer.
Volume: 47
Issue: 4
Pages: 183-90
Publication
First Author: Greulich H
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.
Volume: 109
Issue: 36
Pages: 14476-81
Publication
First Author: Parajuli N
Year: 2010
Journal: Int J Cancer
Title: Infiltrating CD11b+CD11c+ cells have the potential to mediate inducible nitric oxide synthase-dependent cell death in mammary carcinomas of HER-2/neu transgenic mice.
Volume: 126
Issue: 4
Pages: 896-908
Publication
First Author: Muraoka RS
Year: 2003
Journal: Mol Cell Biol
Title: Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.
Volume: 23
Issue: 23
Pages: 8691-703
Protein
Organism: Mus musculus/domesticus
Length: 1450  
Fragment?: false
Publication
First Author: Worzfeld T
Year: 2012
Journal: J Clin Invest
Title: ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.
Volume: 122
Issue: 4
Pages: 1296-305
Publication
First Author: Turcotte M
Year: 2017
Journal: Cancer Res
Title: CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
Volume: 77
Issue: 20
Pages: 5652-5663
Publication
First Author: Muller WJ
Year: 1996
Journal: Mol Cell Biol
Title: Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.
Volume: 16
Issue: 10
Pages: 5726-36
Publication
First Author: Escher P
Year: 2005
Journal: Science
Title: Synapses form in skeletal muscles lacking neuregulin receptors.
Volume: 308
Issue: 5730
Pages: 1920-3
Publication
First Author: Yao S
Year: 2015
Journal: J Pathol
Title: Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR.
Volume: 236
Issue: 1
Pages: 65-77
Publication
First Author: Olejnickova V
Year: 2024
Journal: Dev Dyn
Title: Development of ventricular trabeculae affects electrical conduction in the early endothermic heart.
Volume: 253
Issue: 1
Pages: 78-90
Publication
First Author: Farrell AS
Year: 2013
Journal: Mol Cell Biol
Title: Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.
Volume: 33
Issue: 15
Pages: 2930-49
Publication
First Author: Bershtein LM
Year: 2003
Journal: Bull Exp Biol Med
Title: Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors.
Volume: 135
Issue: 6
Pages: 580-1
Publication
First Author: Bouchard L
Year: 1989
Journal: Cell
Title: Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.
Volume: 57
Issue: 6
Pages: 931-6
Publication
First Author: Chiodoni C
Year: 2020
Journal: Cancer Res
Title: Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAs.
Volume: 80
Issue: 3
Pages: 484-498
Publication
First Author: Creedon H
Year: 2016
Journal: Dis Model Mech
Title: Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer.
Volume: 9
Issue: 2
Pages: 131-40
Publication
First Author: Schade B
Year: 2009
Journal: J Biol Chem
Title: PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.
Volume: 284
Issue: 28
Pages: 19018-26
Publication
First Author: Barbieri I
Year: 2010
Journal: Mol Carcinog
Title: Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
Volume: 49
Issue: 2
Pages: 114-20
Publication
First Author: Blumberg MS
Year: 2015
Journal: Curr Biol
Title: Development of twitching in sleeping infant mice depends on sensory experience.
Volume: 25
Issue: 5
Pages: 656-62
Publication
First Author: Guertin AD
Year: 2005
Journal: J Neurosci
Title: Microanatomy of axon/glial signaling during Wallerian degeneration.
Volume: 25
Issue: 13
Pages: 3478-87
Publication
First Author: Wilson SJ
Year: 2006
Journal: Biochim Biophys Acta
Title: Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia.
Volume: 1762
Issue: 7
Pages: 647-55
Publication
First Author: Tanowitz M
Year: 1999
Journal: J Neurosci
Title: Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.
Volume: 19
Issue: 21
Pages: 9426-35